Corveus Medical
YC W22 ↗Houston, US · Founded 2021 · 3 employees · 3 known investors
Corveus Medical develops a minimally-invasive catheter-based treatment that deactivates a sympathetic nerve branch to address heart failure progression. The company targets physicians treating heart failure patients with limited therapeutic options.
Founders & leadership· Y Combinator alumni (W22)
Investors · 3
In the news
- 2025 Houston Innovation Awards finalists: Health Tech Business - InnovationMaphouston.innovationmap.com · 2025
- Corveus Medical Joins Fogarty Innovation to Tackle Heart Failure - Fogarty Innovationfogartyinnovation.org · 2024
- MedTech Innovator selects Prana Thoracic, Ankr, NeuraStasis, Nininger Medical - InnovationMaphouston.innovationmap.com · 2023


